Skip to main content
. Author manuscript; available in PMC: 2018 Apr 12.
Published in final edited form as: J Card Fail. 2018 Feb 7;24(4):249–254. doi: 10.1016/j.cardfail.2018.01.011

Table 3.

Changes in therapeutic parameters associating with GI bleeding

Pre-octreotide period Post-octreotide period P value
Mean hemoglobin level, g/dL 9.24 ± 0.84 9.82 ± 0.83 0.003*
Per year amount
  RBC, unit/year 20.2 ± 24.6 7.1 ± 10.3 0.002*
  FFP, unit/year 13.1 ± 19.1 3.6 ± 5.0 0.002*
  LOS, day/year 35.4 ± 47.3 8.7 ± 28.3 <0.001*
  GI procedure, time/year 2.9 ± 3.1 0.4 ± 0.7 <0.001*
Per event amount
  RBC, unit/event 2.5 ± 2.7 1.0 ± 1.7 0.004*
  FFP, unit/event 1.3 ± 2.1 0.1 ± 0.4 0.001*
  LOS, day/event 9.1 ± 6.3 4.5 ± 7.9 0.015*
  GI procedure, time/event 0.8 ± 0.2 0.3 ± 0.5 <0.001*

RBC, red blood cell; FFP, fresh frozen plasma; LOS, length of stay.

*

p <0.05 by Wilcoxon signed-rank test